Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Clinical experience with b12 injections for other indications does not include nausea reduction as a known effect
The weight comes off
Who qualifies for Foundayo BMI and weight requirements Foundayo is FDA-approved for adults with obesity (BMI of 30 or higher) or adults with overweight (BMI of 27 or higher) who have at least one weight-related health condition
Semaglutide selectively activates the GLP-1 receptor, producing: Glucose-dependent insulin secretion : Reduces hypoglycemia risk compared to non-incretin agents Glucagon suppression : Reduces hepatic glucose output in the hyperglycemic state Gastric emptying delay : Contributes to postprandial glucose control and satiety Central appetite regulation : Acts on GLP-1 receptors in the hypothalamus and brainstem to reduce hunger and alter food preferences The simplicity of semaglutide's single-receptor mechanism is both a limitation (no energy expenditure enhancement from glucagon) and a strength (thoroughly understood pharmacology, predictable effects, extensive safety characterization)
Yes, you can switch from oral semaglutide to injectable tirzepatide
US$ 29.92
US$ 23.13
US$ 23.82
